Klaria Pharma Holding AB
Develops rapid-acting drugs using an oral film for transmucosal delivery.
KLAR | ST
Overview
Corporate Details
- ISIN(s):
- SE0007280326
- LEI:
- 529900YLMSNHNP7HOD11
- Country:
- Sweden
- Address:
- Virdings Allé 2, 754 50 UPPSALA
- Website:
- https://klaria.com/
- Sector:
- Manufacturing
Description
Klaria Pharma Holding AB is a pharmaceutical company that develops innovative, rapid-acting medicinal products. The company's core technology is a proprietary transmucosal drug delivery platform. This platform uses an alginate-based polymer film that adheres to the oral mucosa, enabling fast and direct absorption of active pharmaceutical ingredients into the bloodstream. This delivery method offers advantages for conditions requiring a quick onset of effect, bypassing the gastrointestinal tract. The company's development pipeline focuses on therapeutic areas such as migraine, cancer-related pain, and opioid overdose. A key product in its portfolio is a formulation of Sumatriptan for the acute treatment of migraine.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Klaria Pharma Holding AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Klaria Pharma Holding AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Klaria Pharma Holding AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
